Matthew T. Roe, MD

Matthew T. Roe, MD
Division of Cardiology, Duke Clinical Research Institute

Shelly K. Sapp, MS
Senior blostatistician, Cleveland Clinic Cardiovascular Coordinating Center

A. Michael Lincoff, MD
Director, Experiental Interventional Laboratory Department of Cardiology, Cleveland Clinic; Editor of Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Diseases

Address: A. Michael Lincoff, MD, Department of Cardiology, Desk F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Matthew T. Roe, MD
Division of Cardiology, Duke Clinical Research Institute

Shelly K. Sapp, MS
Senior blostatistician, Cleveland Clinic Cardiovascular Coordinating Center

A. Michael Lincoff, MD
Director, Experiental Interventional Laboratory Department of Cardiology, Cleveland Clinic; Editor of Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Diseases

Address: A. Michael Lincoff, MD, Department of Cardiology, Desk F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Matthew T. Roe, MD
Division of Cardiology, Duke Clinical Research Institute

Shelly K. Sapp, MS
Senior blostatistician, Cleveland Clinic Cardiovascular Coordinating Center

A. Michael Lincoff, MD
Director, Experiental Interventional Laboratory Department of Cardiology, Cleveland Clinic; Editor of Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Diseases

Address: A. Michael Lincoff, MD, Department of Cardiology, Desk F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]